1. Eosinophilic “candy floss”-like inclusions in myeloma cells

   • Vikram Narang
   • Man Updesh Singh Sachdeva
   • Neelam Varma

   Images in Hematology 23 April 2013 Pages: 677 - 678

   

2. All that glitters is not gold: differential diagnosis of clover-leaf lymphocytes

   • George Yaghmour
   • Ravneet Thind
   • Philip Kuriakose

   Images in Hematology 27 April 2013 Pages: 679 - 680

   

3. Guest editorial: efficacy of and resistance to molecularly targeted therapy for myeloid malignancies

   • Hitoshi Kiyoi

   Progress in Hematology 12 May 2013 Pages: 681 - 682

4. FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance

   • Michael R. Grunwald
   • Mark J. Levis

   Progress in Hematology 24 April 2013 Pages: 683 - 694

   

5. Sensitivity and resistance of JAK2 inhibitors to myeloproliferative neoplasms

   • Neha Bhagwat
   • Ross L. Levine
   • Priya Koppikar

   Progress in Hematology 14 May 2013 Pages: 695 - 702

   

6. Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia

   • Akihiro Takeshita

   Progress in Hematology 26 May 2013 Pages: 703 - 716

   

7. Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As₂O₃) in acute promyelocytic leukemia

   • Akihiro Tomita
   • Hitoshi Kiyoi
   • Tomoki Naoe

   Progress in Hematology 14 May 2013 Pages: 717 - 725

   

8. A role for RUNX1 in hematopoiesis and myeloid leukemia

   • Motoshi Ichikawa
   • Akihide Yoshimi
   • Mineo Kurokawa

   Review Article 24 April 2013 Pages: 726 - 734

   

9. Treatment of gastric MALT lymphoma with a focus on Helicobacter pylori eradication

   • Qing Guo
   • Shanqi Guo
   • Yizhuo Zhang

   Review Article 25 April 2013 Pages: 735 - 742

   

10. Association of Th1 and Th2 cytokines with transient inflammatory reaction during lenalidomide plus dexamethasone therapy in multiple myeloma

    • Takeshi Harada
    • Shuji Ozaki
    • Masahiro Abe

    Rapid Communication 23 April 2013 Pages: 743 - 748

    

11. Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry

    • Jong Wook Lee
    • Jun Ho Jang
    • Sang Kyun Sohn

    Original Article 01 May 2013 Pages: 749 - 757

    

12. Genotypic and phenotypic features of Japanese patients with mild to moderate hemophilia A

    • Hiroshi Inaba
    • Keiko Shinozawa
    • Katsuyuki Fukutake

    Original Article 27 April 2013 Pages: 758 - 764

13. Bisphosphonate treatment and renal function in 201 myeloma patients undergoing stem cell transplantation

    • S. Schmitt
    • T. Hielscher
    • T. M. Moehler

    Original Article 25 April 2013 Pages: 765 - 772

    

14. Normal karyotype mosaicism in adult AML patients with adverse-risk and undefined karyotype: preliminary report of treatment outcomes after hematopoietic stem cell transplantation

    • Jae-Ho Yoon
    • Hee-Je Kim
    • Chong-Won Park

    Original Article 25 April 2013 Pages: 773 - 781

    

15. Spontaneous remission of 2-chlorodeoxyadenosine (2-CdA)-related secondary myelodysplastic syndrome in a patient with refractory Langerhans cell histiocytosis

    • Daisuke Suzuki
    • Ryoji Kobayashi
    • Kunihiko Kobayashi

    Original Article 25 April 2013 Pages: 782 - 785

    

16. Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22)

    • Lixia Zhang
    • Qinghua Li
    • Yingchang Mi

    Original Article 24 April 2013 Pages: 786 - 792

    

17. IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations

    • H. Dean Hosgood III
    • Wing-Yan Au
    • Qing Lan

    Original Article 03 May 2013 Pages: 793 - 799

18. Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review

    • Emilio Besada
    • Anders Vik
    • Johannes C. Nossent

    Case Report 25 April 2013 Pages: 800 - 803

    

19. Two CML patients who subsequently developed features of essential thrombocythemia with JAK2-V617F mutation while in complete cytogenetic remission after treatment with imatinib mesylate

    • Yoo Jin Lee
    • Joon Ho Moon
    • Sang Kyun Sohn

    Case Report 24 April 2013 Pages: 804 - 807

    

20. Acute myeloid leukemia associated with FGFR1 abnormalities

    • Hyeyoung Lee
    • Myungshin Kim
    • Hee-Je Kim

    Case Report 23 April 2013 Pages: 808 - 812